AF
TXMD icon

Allworth Financial’s TherapeuticsMD TXMD Stock Holding History

Allworth Financial’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10
Closed -$2K – 1044
2019
Q1 		$2K Hold
10
– – ﹤0.01% 857
2018
Q4 		$2K Hold
10
– – ﹤0.01% 767
2018
Q3 		$3K Hold
10
– – ﹤0.01% 758
2018
Q2 		$3K Hold
10
– – ﹤0.01% 752
2018
Q1 		$2K Hold
10
– – ﹤0.01% 726
2017
Q4 		$3K Hold
10
– – ﹤0.01% 638
2017
Q3 		$3K Hold
10
– – ﹤0.01% 644
2017
Q2 		$3K Buy
10
+8
+400% +$2K ﹤0.01% 646
2017
Q1 		$1K Hold
2
– – ﹤0.01% 719
2016
Q4 		$1K Hold
2
– – ﹤0.01% 639
2016
Q3 		$1K Buy
+2
New +$730 ﹤0.01% 663

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allworth Financial's TXMD Position: Q2 2019 in Review

Allworth Financial sold out of TherapeuticsMD (TXMD) in Q2 2019, closing a stake of 10 shares — an estimated $2K sold.

Allworth Financial first reported a position in TXMD in Q3 2016 and held it in 11 quarters. The position peaked at $3K in Q3 2018. 148 funds tracked by Wall St. Rank hold TXMD as of Q2 2019.

  • Allworth Financial reported no remaining TherapeuticsMD position as of Q2 2019 after selling out during the quarter.
  • Allworth Financial sold 10 TherapeuticsMD shares in Q2 2019, an estimated $2K.
  • Allworth Financial first reported a position in TherapeuticsMD in Q3 2016 and held it in 11 quarters.
  • Allworth Financial's TherapeuticsMD position peaked at $3K in Q3 2018.
  • 148 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2019.

Based on Allworth Financial's 13F filing for Q2 2019, filed 25 Jul 2019.